Erythrodermic psoriasis treated with apremilast

  • John Arcilla Department of Medicine, Loma Linda University School of Medicine, VA Loma Linda Healthcare System, Loma Linda, CA, United States.
  • Daniel Joe Department of Medicine, Loma Linda University School of Medicine, VA Loma Linda Healthcare System, Loma Linda, CA, United States.
  • Johnathan Kim Department of Medicine, Loma Linda University School of Medicine, VA Loma Linda Healthcare System, Loma Linda, CA, United States.
  • Yohanan Kim Department of Medicine, Loma Linda University School of Medicine, VA Loma Linda Healthcare System, Loma Linda, CA, United States.
  • VuAnh N. Truong Department of Medicine, Loma Linda University School of Medicine, VA Loma Linda Healthcare System, Loma Linda, CA, United States.
  • Navin Jaipaul | Navin.Jaipaul@va.gov Department of Medicine, Loma Linda University School of Medicine and Department of Medicine, VA Loma Linda Healthcare System, Loma Linda, CA, United States.

Abstract

Erythroderma is a rare potentially deadly exfoliative dermatitis characterized by diffuse cutaneous erythema which may be associated with multi-organ dysfunction. Therefore, it is imperative to recognize and treat it promptly. Erythrodermic psoriasis is the most common form of erythroderma. Management of this condition is largely based on aggressive supportive care and the use of anti-inflammatory immunosuppressive and biologic agents. We describe a case of psoriatic erythroderma which was triggered by withdrawal from systemic steroids and successfully treated with apremilast and cyclosporine. Apremilast induced atrial fibrillation limited its continued use after the initial response period.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Author Biography

Navin Jaipaul, Department of Medicine, Loma Linda University School of Medicine and Department of Medicine, VA Loma Linda Healthcare System, Loma Linda, CA

Department of Medicine

Division of Nephrology

Associate Professor of Medicine

Published
2016-09-19
Info
Issue
Section
Case Reports
Keywords:
Erythroderma, Psoriasis, Erythrodermic psoriasis, Apremilast.
Statistics
  • Abstract views: 1286

  • PDF: 482
  • HTML: 568
How to Cite
Arcilla, J., Joe, D., Kim, J., Kim, Y., Truong, V., & Jaipaul, N. (2016). Erythrodermic psoriasis treated with apremilast. Dermatology Reports, 8(1). https://doi.org/10.4081/dr.2016.6599